Sophia Ran received the Ph.D. degree in biochemistry from the Weizmann Institute in Rehovot, Israel, in 1989. She completed postgraduate training in cellular physiology and protein purification of ion transporters in the Hospital for Sick Children, Toronto, Canada, and the University of Alabama at Birmingham, USA, in 1991 and 1992, respectively. From 1992 to 1995, Ran was a Senior Research Scientist in American Cyanamid Company, USA. From 1998 to 2003, she was a Research Assistant Professor in the University of Texas, Southwestern Medical Center in Dallas, Tex, USA. In 2003, she moved to Southern Illinois University in Springfield, Ill, USA, where she is currently an Associate Professor in the department of Medical Microbiology, Immunology, and Cell Biology and a Member of Simmons Cancer Institute. Her major research interests are pathophysiology of tumor vasculature and metastasis in breast cancer. Ran developed several reagents and therapeutic approaches targeting tumor vasculature currently undergoing clinical trials. Ran is the Author of 19 US and 66 international patents. During her career, she published 40 papers related mainly to tumor angiogenesis, lymphangiogenesis, anticancer therapies, and hematogenous and lymphatic metastasis. Ran is a Member of Research Advisory Board of American Cancer Society (Illinois Division) and an Associate Editor of Frontiers in Vascular Physiology. She serves as a grant reviewer for several US and international agencies including American Cancer Society (USA), the Florida Department of Health (USA), the US Army Medical Research and Material Command (USA), Cancer Research Council (England), Italian Ministry of Health (Italy), the Swiss Cancer League, and the Swiss National Foundation (Switzerland).
Biography Updated on 29 November 2010